Most Read Articles
5 days ago
Among postmenopausal women, short sleep duration and depression contribute to increased fall accidents, as reported in a study.
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.

Some antihypertensive meds tied to lower dementia risk

Roshini Claire Anthony
20 Aug 2020

Calcium channel blockers (CCBs) and angiotensin II receptor blockers (ARBs) may be associated with a reduced risk of dementia, according to a systematic review and network meta-analysis conducted by researchers from the Netherlands.

The researchers reviewed 15 observational studies and seven randomized controlled trials (RCTs) comprising 649,790 individuals (median age 74 years) who had been receiving antihypertensive medications for >1 year. After a median follow-up period of 4.3 years, 3.02 percent (n=19,600) were diagnosed with dementia.

Review of the observational studies showed that CCBs were associated with a reduced risk of dementia compared with angiotensin-converting enzyme (ACE) inhibitors (hazard ratio [HR], 0.84, 95 percent confidence interval [CI], 0.74–0.95), beta blockers (HR, 0.83, 95 percent CI, 0.73–0.95), and diuretics (HR, 0.89, 95 percent CI, 0.78–1.01). [AAIC 2020, abstract ODO4-08-06]

The risk of dementia was also lower with use of ARBs compared with ACE inhibitors (HR, 0.88, 95 percent CI, 0.81–0.97), beta blockers (HR, 0.87, 95 percent CI, 0.77–0.99), and diuretics (HR, 0.93, 95 percent CI, 0.83–1.05).

“[T]he use of CCBs was associated with a 16–17 percent risk reduction and the use of ARBs with a 12–13 percent risk reduction in dementia incidence compared with beta blockers and ACE inhibitors,” said Dr Melina den Brok from Radboud University Medical Center, Nijmegen, the Netherlands, who presented the results at AAIC 2020.

“Recommending CCBs or ARBs as preferred first-line antihypertensive treatment may significantly reduce the risk of dementia,” she said.

Den Brok noted that the small number of RCTs rendered less robust results and precluded conclusions from being drawn on these associations. “[Nonetheless,] if confirmed in a randomized setting, CCBs and ARBs as standard therapy for hypertension may be a low-cost and easy to implement prevention strategy to reduce the risk of dementia globally,” she concluded.

 

Candesartan improves cognition in patients with MCI

A separate study on older individuals with mild cognitive impairment (MCI)* suggested that the ARB candesartan had a better effect on cognition than the ACE inhibitor lisinopril.

Participants in the phase 2 CALIBREX** study were 176 individuals aged 55 years with MCI and hypertension. Their ongoing antihypertensive therapy was initially withdrawn, and they were randomized to receive increasing doses of candesartan (up to 32 mg/day) or lisinopril (up to 40 mg/day). If required, antihypertensive treatments were added to achieve a target blood pressure (BP) of <140/90 mm Hg. BP control was comparable between groups during the trial.

Assessment of the 141 patients included (mean age 65 years, 55 percent female) showed that at 12 months, executive function, based on Trail Making Test Parts A and B (TMT, B-A), improved in candesartan recipients and worsened in lisinopril recipients (-16.8 vs 11.5 seconds; p=0.008). [AAIC 2020, abstract ODO3-06-06]

There was a greater improvement in delayed recall, assessed by the Hopkins Verbal Learning Test-Revised (HVLT-R), with candesartan vs lisinopril (difference, 1.0 vs 0.3; p=0.026). Microvascular brain injury, assessed as change in white matter lesion volume, did not significantly change with candesartan (0.2 mm3), though lisinopril recipients experienced an increase (0.9 mm3; p=0.06).

“Candesartan demonstrates superior cognitive outcomes compared to lisinopril and may offer unique neurocognitive protection in older adults with executive MCI and hypertension,” said the researchers.

“These effects were independent of but likely additive to BP-lowering properties,” presented Associate Professor Ihab Hajjar from the Emory University School of Medicine, Atlanta, Georgia, US, who noted that the findings require confirmation in larger studies.

 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
Among postmenopausal women, short sleep duration and depression contribute to increased fall accidents, as reported in a study.
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.